Growth Metrics

Entera Bio (ENTX) Other Working Capital Changes (2018 - 2025)

Entera Bio has reported Other Working Capital Changes over the past 8 years, most recently at $10000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 135.71% year-over-year to $10000.0, compared with a TTM value of $229000.0 through Dec 2025, up 1535.71%, and an annual FY2025 reading of $229000.0, up 1535.71% over the prior year.
  • Other Working Capital Changes came in at $10000.0 for Q4 2025, up from -$33000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $745000.0 in Q2 2021 to a low of -$760000.0 in Q3 2021.
  • Median Other Working Capital Changes over the past 5 years was -$28000.0 (2024), compared with a mean of $1526.3.
  • The sharpest move saw Other Working Capital Changes skyrocketed 2493.33% in 2023, then plummeted 2966.67% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $15000.0 in 2021, then crashed by 4893.33% to -$719000.0 in 2022, then surged by 76.36% to -$170000.0 in 2023, then soared by 83.53% to -$28000.0 in 2024, then surged by 135.71% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Other Working Capital Changes are $10000.0 (Q4 2025), -$33000.0 (Q3 2025), and -$81000.0 (Q2 2025).